الفهرسة نشطة
للباحثين للناشرين تسجيل الدخول إنشاء حساب
الرئيسية المؤلفون Riad El Fakih
RF

Riad El Fakih

h-6 H-Index
152 Citations
15 Papers

Published Papers

15 indexed
1
The Risk and Prognosis of COVID-19 Infection in Cancer Patients
Hematology/Oncology and Stem Cell Therapy Q3 2022 10.1016/j.hemonc.2020.07.005
80 citations 398
2
Chimeric Antigen Receptor Structure and Manufacturing of Clinical Grade CAR Engineered Cells using Different Bioreactors
Hematology/Oncology and Stem Cell Therapy Q3 2022 10.56875/2589-0646.1048
16 citations 391
3
Diagnosis and Treatment of Subcutaneous Panniculitis-like T-cell Lymphoma: A Systematic Literature Review
Hematology/Oncology and Stem Cell Therapy Q3 2023 10.1016/j.hemonc.2021.04.001
15 citations 392
4
Strategic priorities for hematopoietic stem cell transplantation in the EMRO region
Hematology/Oncology and Stem Cell Therapy Q3 2023 10.1016/j.hemonc.2021.09.006
12 citations 392
5
Hematologic Manifestations of Parvovirus B19 Infection
Hematology/Oncology and Stem Cell Therapy Q3 2023 10.56875/2589-0646.1031
12 citations 393
6
Role of Anti-CD38 Monoclonal Antibodies in the Treatment of Adult Immune Hematological Diseases
Hematology/Oncology and Stem Cell Therapy Q3 2023 10.56875/2589-0646.1108
6 citations 393
7
H syndrome: A histiocytosis-lymphadenopathy plus syndrome. A comprehensive review of the literature
Hematology/Oncology and Stem Cell Therapy Q3 2024 10.4103/hemoncstem.hemoncstem-d-24-00004
5 citations 392
8
Philadelphia Chromosome-Positive T-cell Acute Lymphoblastic Leukemia
Hematology/Oncology and Stem Cell Therapy Q3 2022 10.1016/j.hemonc.2020.02.004
4 citations 390
9
Patterns of Graft-Versus-Host Disease (GvHD) Prevention Practices in the Eastern Mediterranean (EM) Region: A Worldwide Network for Blood & Marrow Transplantation (WBMT) Global Study
Hematology/Oncology and Stem Cell Therapy Q3 2025 10.4103/hemoncstem.hemoncstem-d-25-00004
1 citations 394
10
Improved long-term survival rate in the responders to bortezomib, cyclophosphamide, dexamethasone induction therapy in a transplant-eligible cohort of predominantly middle-age multiple myeloma patients
Annals of Saudi Medicine Q1 2024 10.5144/0256-4947.2024.93
1 citations 2,141
11
Framework for Patient Advocacy in Hematopoietic Cell Transplantation (HCT): An Overview from the Worldwide Network for Blood and Marrow Transplantation
Hematology/Oncology and Stem Cell Therapy Q3 2025 10.4103/hemoncstem.hemoncstem-d-24-00054
0 citations 394
12
Acute and chronic graft-versus-host disease treatment and management in the Eastern Mediterranean region: A Worldwide Network for Blood and Marrow Transplantation survey
Hematology/Oncology and Stem Cell Therapy Q3 2025 10.4103/hemoncstem.hemoncstem-d-25-00005
0 citations 394
13
Cancer epidemiology in the Kingdom of Saudi Arabia, 2024
Hematology/Oncology and Stem Cell Therapy Q3 2026 10.4103/hemoncstem.hemoncstem-d-26-00008
0 citations 395
14
Progressive transformation of germinal centers: Bridging clinical and pathological insights for diagnostic precision
Hematology/Oncology and Stem Cell Therapy Q3 2026 10.4103/hemoncstem.hemoncstem-d-25-00052
0 citations 392
15
Revisiting autologous stem cell transplantation for LBCL in the CAR T-Cell era
Hematology/Oncology and Stem Cell Therapy Q3 2026 10.4103/hemoncstem.hemoncstem-d-26-00022
0 citations 396

Publication Activity

Journals Published In

Annals of Saudi Medicine
🇸🇦 Q1 AMS 90
Hematology/Oncology and Stem Cell Therapy
🇸🇦 Q3 AMS 72